Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.80 |
| ▸ | MEN1 | O00255 | 1/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.80 |
| ▸ | CA5A | P35218 | 2/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | NT5E | P21589 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL8192555 | 0.89 | TSHR (0.80) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL8192552 | 0.89 | TSHR (0.80) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL21815678 | 0.89 | TSHR (0.80) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL2814083 | 0.89 | — | — | |
| Sulfuric Acid SCHEMBL4306353 | 0.89 | TSHR (0.80) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL7645188 | 0.89 | TSHR (0.80) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL27312 | 0.89 | — | — | |
| Sulfuric Acid SCHEMBL21815641 | 0.89 | TSHR (0.80) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL6380732 | 0.89 | TSHR (0.80) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL1291603 | 0.89 | TSHR (0.80) | TSHRMEN1ALDH1A1KMT2ACA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678725-A1 | CO-GRANULES COMPRISING BLEACHING CATALYST, BLEACHING ACTIVATOR, BINDER AND ZINC OR BISMUTH SALT, AND BLEACHING AND CLEANING AGENT COMPRISING SAME | Catexel GmbH (DE) | 2026-01-14 | — | — | EP | claimed |
| EP-1683515-A2 | Bismuth-containing compounds in topical dosage forms | Josman Laboratories, Inc. (US) | 2006-07-26 | — | — | EP | claimed |
| EP-0879035-B1 | BISMUTH-CONTAINING COMPOSITIONS IN TOPICAL DOSAGE FORMS | JOSMAN LAB INC (US) | 2006-06-14 | — | — | EP | claimed |
| US-20060088481-A1 | Topical oral dosage forms containing bismuth compounds | ATHANIKAR NARAYAN K | 2006-04-27 | — | — | US | claimed |
| US-6902738-B2 | Topical oral dosage forms containing bismuth compounds | JOSMAN LABORATORIES, INC. (US) | 2005-06-07 | — | — | US | claimed |
| US-20030118517-A1 | Topical oral dosage forms containing bismuth compounds | ATHANIKAR NARAYAN K (US) | 2003-06-26 | — | — | US | claimed |
| US-6426085-B1 | BACTERICIDES | JOSMAN LABORATORIES INC. | 2002-07-30 | — | — | US | claimed |
| US-6379651-B1 | ADMINISTERING AND INGESTING PERORAL TABLETS OF AN ANTIBIOTIC/ANTIBACTERIAL COMPOUND WITH A BISMUTH COMPOUND, AND CHEWING WITHIN ORAL CAVITY | JOSMAN LABORATORIES | 2002-04-30 | — | — | US | claimed |
| US-6372784-B1 | STIMULANTING CELL PRODUCTION OR RELEASE OF GROWTH FACTORS | JOSMAN LABORATORIES, INC. | 2002-04-16 | — | — | US | claimed |
| EP-0879035-A4 | BISMUTH-CONTAINING COMPOUNDS IN TOPICAL DOSAGE FORMS | JOSMAN LAB INC (US) | 2001-10-31 | — | — | EP | claimed |
| EP-0879035-A1 | BISMUTH-CONTAINING COMPOUNDS IN TOPICAL DOSAGE FORMS | Josman Laboratories, Inc. (US) | 1998-11-25 | — | — | EP | claimed |
| WO-1997007757-A1 | BISMUTH-CONTAINING COMPOUNDS IN TOPICAL DOSAGE FORMS | JOSMAN LABORATORIES, INC. (US) | 1997-03-06 | — | — | WO | claimed |
| CN-114846044-B | Electrodepositable coating composition | PPG工业俄亥俄公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-117769585-A | Electrodepositable coating composition | PPG工业俄亥俄公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-117751168-A | Electrodepositable coating composition | PPG工业俄亥俄公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117715991-A | Electrodepositable coating composition | PPG工业俄亥俄公司 | 2024-03-15 | — | — | CN | disclosed |
| WO-1997007757-A1 | BISMUTH-CONTAINING COMPOUNDS IN TOPICAL DOSAGE FORMS | JOSMAN LABORATORIES, INC. (US) | 1997-03-06 | — | — | WO | disclosed |
| WO-1996024341-A9 | CONCOMITANT TREATMENT WITH BISMUTH AND ANTIBACTERIALS | — | 1996-10-03 | — | — | WO | disclosed |
| WO-1996024341-A1 | CONCOMITANT TREATMENT WITH BISMUTH AND ANTIBACTERIALS | ATHANIKAR NARAYAN KRISHNARAO (US) | 1996-08-15 | — | — | WO | disclosed |
| WO-1996024342-A1 | CONCOMITANT TREATMENT WITH ORAL BISMUTH COMPOUNDS | ATHANIKAR NARAYAN KRISHNARAO (US) | 1996-08-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118517-A1 | Topical oral dosage forms containing bismuth compounds | FHIT, NISCH, CUTA | TSHR 3042/4885MEN1 1675/4885ALDH1A1 1787/4885 |
| US-20060088481-A1 | Topical oral dosage forms containing bismuth compounds | FHIT, NISCH, CUTA | TSHR 3042/4885MEN1 1675/4885ALDH1A1 1787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.